Legal status · Canada
Is MK-677 with ipamorelin legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. MK-677 with ipamorelin is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
MK-677 with ipamorelin in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the MK-677 with ipamorelin profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing MK-677 with ipamorelin is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What MK-677 with ipamorelin is
Not one vial but one protocol: a daily oral secretagogue alongside an injected one. Both act at the same receptor, so this is a single mechanism delivered twice. MK-677 is the only component in the growth hormone section of this database with a two-year randomised trial, and that trial showed fat-free mass rose 1.1 kg against a 0.5 kg fall on placebo, with no significant strength or function benefit.
People run these together because one is convenient and slow and the other is injected and fast, and the combination feels like covering both. Pharmacologically it is one receptor, hit twice.
Mechanism: Both components are agonists at the growth hormone secretagogue receptor. MK-677 is orally bioavailable with a long enough duration to sustain raised growth hormone and IGF-1 across the day; ipamorelin is injected and short acting.
Regulatory history: Not approved. MK-677 completed clinical development without an approval and is sold as a research chemical; ipamorelin has never been approved.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for MK-677 with ipamorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
MK-677 with ipamorelin in other countries
Frequently asked questions
Is MK-677 with ipamorelin legal in Canada?
No. MK-677 with ipamorelin is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy MK-677 with ipamorelin in Canada?
No approved product exists to buy. In Canada MK-677 with ipamorelin is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is MK-677 with ipamorelin Health Canada approved?
No. In Canada MK-677 with ipamorelin is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved. MK-677 completed clinical development without an approval and is sold as a research chemical; ipamorelin has never been approved.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for MK-677 with ipamorelin live on its compound profile.
MK-677 with ipamorelin profileThis page is general information about the regulatory status of MK-677 with ipamorelin in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.